This Republic Day, Dr. Morepen (NSE:MOREPENLAB), a name synonymous with trust and innovation in healthcare, proudly ...

Ralf-Gordon Jahns explores the competitive, yet fragile landscape of mobile apps in this article in pharmaphorum's digital and social media themed month. 65% of all time downloads from the ...

A patient sitting in their home with the phone app open, tracking their diabetes in real-time. Senseonics Holdings (NYSEAMERICAN:SENS) makes implantable continuous glucose monitoring (CGM ...

AI is no longer a luxury, but a necessity; its transformative solutions and methods cutting across industries to enhance ...

With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick.

Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) da ...

Senseonics Holdings (NYSEAMERICAN:SENS) makes implantable continuous glucose monitoring (CGM) systems that help people with diabetes track their blood sugar in real time. It offers the Eversense ...

Glucotrack, Inc., a medical technology company specializing in diabetes solutions, announced it has achieved ISO 13485:2016 certification from the British Standards Institute, marking a ...

Teach participants to recognize personal triggers for slips, their reactions to those slips, and what it takes to get back on track. Session 13. Jump Start Your Activity Plan Introduce the basic ...